🔗 Permalink

Inventor profile of:

Curtis WRIGHT

City:

Norwalk, Connecticut

Country:

United States

Published Applications:

Last publication date:

2019-11-21

Top Assignees for applications by Curtis WRIGHT

The entities that hold a legal rights for patent applications filed by inventor WRIGHT Curtis:

Purdue Pharma L.P. 38 Stamford, CT United States
PURDUE PHARMA L.P. 4 STAMFORD, CO United States
Euro-Celtique S.A. 3 Luxembourg, Luxembourg
Purdue Pharmaceuticals L.P. 3 Wilson, NC United States
The P.F. Laboratories, Inc. 3 Totowa, NJ United States

Recent patent applications by WRIGHT Curtis

Curtis WRIGHT from Norwalk, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-11-21

US20190350868A1

Human necessities

Tamper resistant oral opioid agonist formulations

#2 | 2018-02-15

US20180042859A1

Human necessities

Tamper resistant oral opioid agonist formulations

#3 | 2017-05-04

US20170119685A1

Human necessities

Tamper resistant oral opioid agonist formulations

#4 | 2015-07-02

US20150182467A1

Human necessities

Tamper-resistant oral opioid agonist formulations

#5 | 2015-05-21

US20150140095A1

Human necessities

Once-a-day oxycodone formulations

#6 | 2015-04-23

US20150110879A1

Human necessities

Opioid agonist formulations with releasable and sequestered antagonist

#7 | 2015-03-19

US20150080423A1

Human necessities

PHARMACEUTICAL COMBINATIONS OF HYDROCODONE AND NALTREXONE

#8 | 2014-10-02

US20140296276A1

Human necessities

SEQUESTERED ANTAGONIST FORMULATIONS

#9 | 2014-07-17

US20140199383A1

Human necessities

ABUSE RESISTANT OPIOID CONTAINING TRANSDERMAL SYSTEMS

#10 | 2014-04-10

US20140099376A2

Human necessities

Sequestered antagonist formulations

#11 | 2014-04-10

US20140099369A1

Human necessities

Tamper-resistant oral opioid agonist formulations

#12 | 2013-11-28

US20130317051A1

Human necessities

Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent

#13 | 2013-11-21

US20130309303A1

Human necessities

Opiod agonist formulations with releasable and sequestered antagonist

#14 | 2013-09-26

US20130251812A1

Human necessities

SEQUESTERED ANTAGONIST FORMULATIONS

#15 | 2013-09-26

US20130251789A1

Human necessities

Tamper-resistant oral opioid agonist formulations

#16 | 2012-11-15

US20120288567A1

Human necessities

Opioid agonist formulations with releasable and sequestered antagonist

#17 | 2012-11-15

US20120288565A1

Human necessities

Tamper-resistant oral opioid agonist formulations

#18 | 2012-05-03

US20120108622A1

Human necessities

Pharmaceutical formulation containing gelling agent

#19 | 2011-10-20

US20110256226A1

Human necessities

Opioid agonist formulations with releasable and sequestered antagonist

#20 | 2011-09-22

US20110230510A1

Human necessities

Pharmaceutical formulations containing opioid agonist, opioid antagonist and gelling agent

#21 | 2011-05-17

US10199972

Pharmaceutical combinations of oxycodone and naloxone

#22 | 2011-05-05

US20110104214A1

Human necessities

ONCE-A-DAY OXYCODONE FORMULATIONS

#23 | 2011-04-28

US20110097404A1

Human necessities

Tamper-resistant oral opioid agonist formulations

#24 | 2011-03-29

US10213919

Opioid agonist formulations with releasable and sequestered antagonist

#25 | 2010-12-07

US10476409

Once-a-day oxycodone formulations

#26 | 2010-11-30

US10689866

Tamper-resistant oral opioid agonist formulations

#27 | 2010-11-30

US10214413

Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent

#28 | 2010-09-07

US10401111

Sustained-release gel coated compositions

#29 | 2010-07-01

US20100168148A1

Human necessities

Pharmaceutical formulation containing gelling agent

#30 | 2009-03-26

US20090081287A1

Human necessities

Pharmaceutical composition containing gelling agent

#31 | 2008-12-25

US20080319085A1

Human necessities

Titration dosing regimen for controlled release tramadol

#32 | 2008-12-18

US20080311199A2

Human necessities

Tamper-resistant oral opioid agonist formulations

#33 | 2008-12-18

US20080311198A2

Human necessities

Tamper-resistant oral opioid agonist formulations

#34 | 2008-12-11

US20080306104A2

Human necessities

Tamper-resistant oral opioid agonist formulations

#35 | 2008-12-11

US20080305167A2

Human necessities

Tamper-resistant oral opioid agonist formulations

#36 | 2008-08-19

US10800254

Titration dosing regimen for controlled release tramadol

#37 | 2006-12-05

US10213921

Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent

#38 | 2006-11-28

US10213920

Pharmaceutical formulation containing bittering agent

#39 | 2006-08-31

US20060194826A1

Human necessities

Pharmaceutical combinations of hydrocodone and naltrexone

#40 | 2006-08-17

US20060182801A1

Human necessities

Sequestered antagonist formulations

#41 | 2006-02-23

US20060039970A1

Human necessities

Tamper-resistant oral opioid agonist formulations

#42 | 2005-08-18

US20050181046A1

Human necessities

Tamper-resistant oral opioid agonist formulations

#43 | 2005-05-05

US20050095291A1

Human necessities

Tamper-resistant oral opioid agonist formulations

#44 | 2005-03-24

US20050063909A1

Human necessities

Oral dosage form comprising a therapeutic agent and an adverse-effect agent

InventorID:

455313 ⎘